Matches in SemOpenAlex for { <https://semopenalex.org/work/W4243770036> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W4243770036 endingPage "143" @default.
- W4243770036 startingPage "143" @default.
- W4243770036 abstract "Optimal management of testicular cancer: from self-examination to treatment of advanced disease Stephen DW BeckDepartment of Urology, Indiana University, Indianapolis, Indiana, USAAbstract: Germ-cell cancer is the most common solid tumor in men aged 15 to 35 years and has become the model for curable neoplasm. Over the last 3 decades, the cure rate has increased from 15% to 85%. This improved cure rate has been largely attributed to the introduction of cisplatin-based chemotherapy. In stage I seminoma and nonseminoma, cure rates approach 100% and treatment is governed by patient choice based on the perceived morbidities of each therapy and personal preferences. For seminoma, treatments include surveillance, radiotherapy, and single course carboplatin. For nonseminoma, treatments include surveillance, retroperitoneal lymph node dissection (RPLND), and adjuvant chemotherapy. Low volume (<3 cm) stage II seminoma is typically managed with radiotherapy while higher volume (>3 cm) stage II and stage III disease treated with chemotherapy. Positron emission tomography (PET) imaging can differentiate active cancer versus necrosis for postchemotherapy residual masses. PET-positive masses are managed with either surgery or second-line chemotherapy. Low volume (<5 cm) stage II nonseminoma with normal serum tumor markers may be managed with either RPLND or chemotherapy. Patients with persistently elevated serum tumor markers and larger volume stage II and stage III disease are managed with systemic chemotherapy. As with seminoma, good risk patients are typically treated with 3 courses of bleomycin, etoposide, and cisplatin (BEP) and intermediate and poor risk patients are treated with 4 courses. Residual postchemotherapy masses should be resected due to the uncertainty of the histology with 50% to 60% harboring residual teratoma or active cancer. The majority of patients completing initial therapy who relapse do so within 2 years. A minority of patients (2%–3%) recur after 2 years and this phenomenon is termed late relapse. Excluding chemonaïve patients, late relapse disease is typically managed surgically with 50% being cured of disease. Current therapeutic challenges in testis cancer include the accurate prediction of postchemotherapy histology to avoid surgery in patients harboring fibrosis only, improved therapy in platinum-resistant and platinum-refractory disease, and the understanding of the biology of late relapse.Keywords: testicular cancer, self-examination, advanced disease" @default.
- W4243770036 created "2022-05-12" @default.
- W4243770036 creator A5082433999 @default.
- W4243770036 date "2010-08-01" @default.
- W4243770036 modified "2023-10-18" @default.
- W4243770036 title "Optimal management of testicular cancer: from self-examination to treatment of advanced disease" @default.
- W4243770036 doi "https://doi.org/10.2147/oaju.s7174" @default.
- W4243770036 hasPublicationYear "2010" @default.
- W4243770036 type Work @default.
- W4243770036 citedByCount "2" @default.
- W4243770036 countsByYear W42437700362017 @default.
- W4243770036 countsByYear W42437700362021 @default.
- W4243770036 crossrefType "journal-article" @default.
- W4243770036 hasAuthorship W4243770036A5082433999 @default.
- W4243770036 hasBestOaLocation W42437700361 @default.
- W4243770036 hasConcept C121608353 @default.
- W4243770036 hasConcept C126322002 @default.
- W4243770036 hasConcept C141071460 @default.
- W4243770036 hasConcept C143998085 @default.
- W4243770036 hasConcept C146357865 @default.
- W4243770036 hasConcept C151730666 @default.
- W4243770036 hasConcept C2776212926 @default.
- W4243770036 hasConcept C2776232574 @default.
- W4243770036 hasConcept C2776694085 @default.
- W4243770036 hasConcept C2776938808 @default.
- W4243770036 hasConcept C2778074268 @default.
- W4243770036 hasConcept C2778119113 @default.
- W4243770036 hasConcept C2778239845 @default.
- W4243770036 hasConcept C2779511695 @default.
- W4243770036 hasConcept C2780824555 @default.
- W4243770036 hasConcept C2781451048 @default.
- W4243770036 hasConcept C509974204 @default.
- W4243770036 hasConcept C71924100 @default.
- W4243770036 hasConcept C86803240 @default.
- W4243770036 hasConceptScore W4243770036C121608353 @default.
- W4243770036 hasConceptScore W4243770036C126322002 @default.
- W4243770036 hasConceptScore W4243770036C141071460 @default.
- W4243770036 hasConceptScore W4243770036C143998085 @default.
- W4243770036 hasConceptScore W4243770036C146357865 @default.
- W4243770036 hasConceptScore W4243770036C151730666 @default.
- W4243770036 hasConceptScore W4243770036C2776212926 @default.
- W4243770036 hasConceptScore W4243770036C2776232574 @default.
- W4243770036 hasConceptScore W4243770036C2776694085 @default.
- W4243770036 hasConceptScore W4243770036C2776938808 @default.
- W4243770036 hasConceptScore W4243770036C2778074268 @default.
- W4243770036 hasConceptScore W4243770036C2778119113 @default.
- W4243770036 hasConceptScore W4243770036C2778239845 @default.
- W4243770036 hasConceptScore W4243770036C2779511695 @default.
- W4243770036 hasConceptScore W4243770036C2780824555 @default.
- W4243770036 hasConceptScore W4243770036C2781451048 @default.
- W4243770036 hasConceptScore W4243770036C509974204 @default.
- W4243770036 hasConceptScore W4243770036C71924100 @default.
- W4243770036 hasConceptScore W4243770036C86803240 @default.
- W4243770036 hasLocation W42437700361 @default.
- W4243770036 hasLocation W42437700362 @default.
- W4243770036 hasOpenAccess W4243770036 @default.
- W4243770036 hasPrimaryLocation W42437700361 @default.
- W4243770036 hasRelatedWork W1998333213 @default.
- W4243770036 hasRelatedWork W2031233758 @default.
- W4243770036 hasRelatedWork W2068859133 @default.
- W4243770036 hasRelatedWork W2804633148 @default.
- W4243770036 hasRelatedWork W2890181724 @default.
- W4243770036 hasRelatedWork W3187229375 @default.
- W4243770036 hasRelatedWork W4243770036 @default.
- W4243770036 hasRelatedWork W4250849556 @default.
- W4243770036 hasRelatedWork W2073864770 @default.
- W4243770036 hasRelatedWork W2159264768 @default.
- W4243770036 isParatext "false" @default.
- W4243770036 isRetracted "false" @default.
- W4243770036 workType "article" @default.